Literature DB >> 18834139

Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells.

Marianne D Sadar1, David E Williams, Nasrin R Mawji, Brian O Patrick, Thamrin Wikanta, Ekowati Chasanah, Hari Eko Irianto, Rob Van Soest, Raymond J Andersen.   

Abstract

The new chlorinated peptides sintokamides A to E (1-5) have been isolated from specimens of the marine sponge Dysidea sp. collected in Indonesia. Their structures were elucidated by a combination of spectroscopic and single-crystal X-ray diffraction analyses. Sintokamide A (1) is an inhibitor of N-terminus transactivation of the androgen receptor in prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18834139     DOI: 10.1021/ol802021w

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  42 in total

1.  Concise total synthesis of sintokamides A, B, and E by a unified, protecting-group-free strategy.

Authors:  Zhenhua Gu; Armen Zakarian
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-10       Impact factor: 15.336

Review 2.  Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer.

Authors:  Marianne D Sadar
Journal:  World J Urol       Date:  2011-08-11       Impact factor: 4.226

Review 3.  Small molecule inhibitors targeting the "achilles' heel" of androgen receptor activity.

Authors:  Marianne D Sadar
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

Review 4.  Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain.

Authors:  N G R Dayan Elshan; Matthew B Rettig; Michael E Jung
Journal:  Med Res Rev       Date:  2018-11-22       Impact factor: 12.944

5.  Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis.

Authors:  Shan-Yu Fung; Vladimir Sofiyev; Julia Schneiderman; Aaron F Hirschfeld; Rachel E Victor; Kate Woods; Jeff S Piotrowski; Raamesh Deshpande; Sheena C Li; Nicole J de Voogd; Chad L Myers; Charlie Boone; Raymond J Andersen; Stuart E Turvey
Journal:  ACS Chem Biol       Date:  2013-10-29       Impact factor: 5.100

Review 6.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

Review 7.  Androgen receptor and its splice variants in prostate cancer.

Authors:  Simon Haile; Marianne D Sadar
Journal:  Cell Mol Life Sci       Date:  2011-07-12       Impact factor: 9.261

Review 8.  Beyond castration-defining future directions in the hormonal treatment of prostate cancer.

Authors:  Saroj Niraula; Kim Chi; Anthony Michael Joshua
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

9.  Valence tautomerism in titanium enolates: catalytic radical haloalkylation and application in the total synthesis of neodysidenin.

Authors:  Stéphane Beaumont; Elizabeth A Ilardi; Lucas R Monroe; Armen Zakarian
Journal:  J Am Chem Soc       Date:  2010-02-10       Impact factor: 15.419

Review 10.  Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.

Authors:  Georgios Kallifatidis; James J Hoy; Bal L Lokeshwar
Journal:  Semin Cancer Biol       Date:  2016-06-28       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.